Neuropace Inc (NPCE)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
CEO:
Michael Favet
Employees:
170
455 N. BERNARDO AVENUE, MOUNTAIN VIEW, CA 94043
6502372700

NeuroPace, Inc. develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Data derived from most recent annual or quarterly report
Market Cap 236.524 Million Shares Outstanding25.405 Million Avg 30-day Volume 64.951 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.52
Price to Revenue2.0822 Debt to Equity2.5843 EBITDA-34.623 Million
Price to Book Value5.3883 Operating Margin-65.9609 Enterprise Value105.655 Million
Current Ratio7.518 EPS Growth-1.056 Quick Ratio6.469
1 Yr BETA 0.9717 52-week High/Low 9.5 / 1.22 Profit Margin-77.2466
Operating Cash Flow Growth16.7311 Free Cash Flow to Firm (FCFF) TTM -26.362 Million Free Cash Flow to Equity (FCFE) TTM-25.627 Million
Altman Z-Score-5.6502
Earnings Report2023-11-09

View recent insider trading info

Neuropace Inc YCharts
Yahoo! Finance finviz

Funds Holding NPCE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NPCE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BECKER JOEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2023-07-18 2

LACOB JOSEPH

  • Director
 0 2023-06-07 2

FISCHER FRANK M

  • Director
 0 2023-06-07 1

GEIGER URI

  • Director
 0 2023-06-07 3

ANDRADE LISA

  • Director
 0 2023-06-07 1

RYAN RENEE

  • Director
 0 2023-06-07 1

KUMAR RAKHI

  • Director
 0 2023-06-07 1

FAVET MICHAEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 407,080 2023-02-21 1

RIDLEY IRINA CHIEF LEGAL OFFICER/SECRETARY

  • Officer
 141,139 2023-02-20 1

MORRELL MARTHA CHIEF MEDICAL OFFICER

  • Officer
 137,164 2023-02-20 2

KUHN REBECCA CHIEF FINANCIAL OFFICER

  • Officer
 139,704 2023-02-20 2

ACCELMED PARTNERS II L.P.

  • 10% Owner
 4,432,948 2022-11-21 1

GARFIELD GREG SHAW

  • Director
 18,253 2022-06-13 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
 4,012,281 2021-04-26 0

KCK LTD.

  • 10% Owner
 5,621,111 2021-04-26 0

NORTON EVAN

  • Director
 4,042,657 2021-04-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEUROPACE INC NPCE 2023-09-29 22:15:03 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 21:45:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 21:15:03 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 20:45:05 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 20:15:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 19:45:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 19:15:03 UTC 0.0 0.0 500000
NEUROPACE INC NPCE 2023-09-29 18:45:03 UTC 0.0 0.0 500000
NEUROPACE INC NPCE 2023-09-29 18:15:03 UTC 0.0 0.0 500000
NEUROPACE INC NPCE 2023-09-29 17:45:03 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 17:15:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 16:45:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 16:15:03 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 15:45:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 15:15:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 14:45:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 14:15:04 UTC -0.1978 5.5178 500000
NEUROPACE INC NPCE 2023-09-29 13:45:03 UTC -0.2193 5.5393 500000
NEUROPACE INC NPCE 2023-09-29 13:15:04 UTC -0.2193 5.5393 500000
NEUROPACE INC NPCE 2023-09-29 12:45:05 UTC -0.2193 5.5393 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments